Conselium has completed a search on behalf of Teva Pharmaceuticals. Mr. Jeffery Spalding began his role of VP Global Compliance, Anti-Corruption August 26, 2013, in the company’s office in North Wales, Penn.
Mr. Spalding’s Responsibilities include:
- Provide global support to all Regional Compliance Officers to develop best practice solutions on FCPA compliance consisting of:
Evaluating the Global FCPA Compliance Program
Developing suggestions so the field personnel can implement proposed enhancements
Serve as investigator on any potential FCPA violations
Interact with the OIG to validate that there is a credible FCPA compliance program
Drive education and awareness on FCPA compliance
Mr. Spalding was previously Compliance Officer with Halliburton Energy and Deputy Chief Trial Attorney with the U.S. Department of Justice.
The backbone of Teva Pharmaceutical Industries is its world-leading generic pharmaceuticals business. Through subsidiary Teva Pharmaceuticals USA, the company makes generic versions of brand-name antibiotics, heart drugs, heartburn medications, and more — in all about 300 generic products. Teva’s US generic products include equivalents of such blockbusters as antidepressant Prozac and cholesterol drug Mevacor. The company, Israel’s top drug maker, also develops and manufactures proprietary drugs, including multiple sclerosis treatment Copaxone and Parkinson’s disease treatment Azilect. Its active pharmaceutical ingredients division makes drug components for Teva and other pharmaceutical manufacturers.
Published by Conselium Executive Search, the global leader in compliance search.
